Abstract
Clinical artificial intelligence (AI) adoption-failure is dominantly framed in two ways: as a behavioural problem (clinician resistance, training gap, change-management deficit) addressed by frameworks such as NASSS and CFIR, or as a model-quality problem (accuracy, calibration, fairness) addressed by external validation. Both frames are reparative; they engage after the implementation decision has been made. We argue that the actual failure mode lies upstream, at seven architectural pre-deployment decisions that determine whether any clinical AI system can ever be operationally trusted: workflow-embedding position, decision-rights allocation, accountability routing, error-recovery loop topology, escalation hierarchy, counterfactual visibility, and authority layer. When these decisions are left implicit, even high-accuracy models accumulate workarounds and convert into AI-Shadow-Care, a deployment state in which clinicians acknowledge AI alerts to dismiss them, document around outputs, and route around recommendations. We test this taxonomy by re-coding 12 published clinical-AI deployment cases through the architecture lens, including the 2026 multi-centre prospective validation of the Epic Sepsis Model version 2, in which improved discrimination (AUROC 0.82-0.92) coexisted with persistently low positive predictive value (0.13-0.26) and high alert burden. We propose a pre-deployment seven-question architecture audit and outline implications for procurement, regulation, and reimbursement. Adoption is an architectural choice, not a behavioural outcome.



![Author ORCID: We display the ORCID iD icon alongside authors names on our website to acknowledge that the ORCiD has been authenticated when entered by the user. To view the users ORCiD record click the icon. [opens in a new tab]](https://www.cambridge.org/engage/assets/public/coe/logo/orcid.png)